获批上市！冷冻消融最小针径！

Core Viewpoint - The article highlights the launch of a new generation of targeted cryoablation needles by the company, which features a 1.2mm needle diameter, breaking the traditional limitations of cryoablation technology and setting a new standard for minimally invasive and efficient tumor treatment [2][4]. Group 1: Product Features - The new cryoablation needle utilizes a unique nitrogen Joule-Thomson phase change cooling technology, achieving a 1.2mm ultra-fine needle diameter while maintaining a 3cm ablation diameter [4]. - The device allows for adjustable heating from 40 to 150℃ through PID intelligent temperature control, enabling a balance between minimal invasiveness and sufficient ablation capability [4][5]. - The needle's design significantly reduces the risk of complications such as bleeding and pneumothorax due to its ultra-fine diameter [5]. Group 2: Efficiency and Adaptability - The targeted cryoablation system offers 56 specifications to meet individual clinical needs, including various needle diameters and lengths, allowing for tailored treatment options [6]. - The system achieves rapid cooling to -170℃ within 30 seconds, enhancing the formation of intracellular ice crystals and improving tumor destruction efficiency [7]. - The device features real-time temperature monitoring at the ablation site, providing doctors with better control over the treatment process [7]. Group 3: Operational Improvements - The new cryoablation needle includes enhancements such as a lighter, more flexible delivery tube, improving the puncture experience and accuracy [8]. - Additional features like target area markings and silicone limit rings assist clinicians in managing the core freezing zone and puncture depth effectively [8]. - The device can operate using standard industrial nitrogen as the sole gas source, significantly reducing operational costs to one-tenth of traditional methods [10][13]. Group 4: Company Milestones - The company has achieved significant milestones over the past two decades, including the launch of China's first percutaneous tumor cryoablation system in 2014 and the world's first bronchial cryoablation system in 2024 [10][13]. - The introduction of the 1.2mm cryoablation needle in 2026 marks another breakthrough in the field, pushing the limits of minimally invasive and effective tumor treatment [10][13].